Photoreceptors derived from iPS cells hold promise for retinal diseases

02/3/2010 | MIT Technology Review

Scientists at the University of Washington in Seattle said they used induced pluripotent stem cell technology to turn stem cells derived from human skin cells into photoreceptors, or light-sensing retinal cells. These iPS cells were transplanted into a mouse retina and found to integrate with nearby tissues. The breakthrough could pave the way for new therapies for retinitis pigmentosa, macular degeneration and other retinal conditions.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA